CVS Insider Transactions
| Transaction Date (SEC Report ) |
Reporting Name | Relationship | Shrs. Owned | Type | Acq./Disp. | Shrs. Transacted | Price() | Amount() |
|---|---|---|---|---|---|---|---|---|
| 2023-02-28 | Khichi Samrat S. | officer: EVP, CPO and General Counsel | 47,881 | A-Award | A | 47,881 | 83.54 | 3,999,978.74 |
| 2023-02-28 | Joyner J. David | officer: EVP&President-PharmacyServices | 23,940 | A-Award | A | 23,940 | 83.54 | 1,999,947.60 |
| 2023-02-28 | Chaguturu Sreekanth K | officer: EVP and Chief Medical Officer | 4,105.6327 | F-InKind | D | 120 | 83.54 | 10,024.80 |
| 2023-02-28 | Clark James David | officer: SVP, Cont & Chief Acct Officer | 26,151.2554 | F-InKind | D | 179 | 83.54 | 14,953.66 |
| 2023-02-27 | Shah Prem S | officer: EVP and Co-President of Retail | 44,403.3199 | F-InKind | D | 226 | 85.77 | 19,384.02 |
| 2023-02-27 | PELUSO MICHELLE A | officer: EVP and Co-President of Retail | 222,682 | F-InKind | D | 12,304 | 85.77 | 1,055,314.08 |
| 2023-02-27 | Havanec Laurie P. | officer: EVP and Chief People Officer | 20,386 | F-InKind | D | 4,046 | 85.77 | 347,025.42 |
| 2023-02-27 | Chaguturu Sreekanth K | officer: EVP and Chief Medical Officer | 3,871.6327 | F-InKind | D | 318 | 85.77 | 27,274.86 |
| 2023-02-02 | Lynch Karen S | director, officer: President and CEO | 206,610 | A-Award | A | 206,610 | 0.00 | 0.00 |
| 2023-02-02 | PELUSO MICHELLE A | officer: EVP and Co-President of Retail | 207,465 | A-Award | A | 192,554 | 0.00 | 0.00 |
| 2022-12-31 | Moriarty Thomas M | officer: EVP & General Counsel | 315,273.0221 | F-InKind | D | 292,856 | 93.19 | 27,291,250.64 |
| 2022-12-15 | Moriarty Thomas M | officer: EVP & General Counsel | 0 | M-Exempt | D | 36,490 | 62.21 | 2,270,042.90 |
| 2022-12-15 | Moriarty Thomas M | officer: EVP & General Counsel | 24,248 | M-Exempt | D | 100,976 | 78.05 | 7,881,176.80 |
| 2022-12-15 | Moriarty Thomas M | officer: EVP & General Counsel | 644,619.0221 | M-Exempt | A | 36,490 | 62.21 | 2,270,042.90 |
| 2022-12-15 | Moriarty Thomas M | officer: EVP & General Counsel | 608,129.0221 | S-Sale | D | 36,490 | 98.24 | 3,584,868.83 |
| 2022-12-15 | Moriarty Thomas M | officer: EVP & General Counsel | 709,105.0221 | M-Exempt | A | 100,976 | 78.05 | 7,881,176.80 |
| 2022-12-01 | Clark James David | officer: SVP, Cont & Chief Acct Officer | 26,177.2554 | F-InKind | D | 153 | 101.65 | 15,552.45 |
| 2022-11-29 | Chaguturu Sreekanth K | officer: EVP and Chief Medical Officer | 2,896.7803 | F-InKind | D | 442 | 100.88 | 44,588.96 |
| 2022-11-17 | WELDON WILLIAM C | director | 41,834.4566 | A-Award | A | 1,764.458 | 94.93 | 167,500.00 |
| 2022-11-17 | MILLON JEAN PIERRE | director | 2,811 | A-Award | A | 1,402 | 94.93 | 133,091.86 |
| 2022-11-17 | SCHAPIRO MARY L | director | 14,107.3441 | A-Award | A | 1,764.458 | 94.93 | 167,500.00 |
| 2022-11-17 | Finucane Anne A. | director | 7,320.2482 | A-Award | A | 1,428 | 94.93 | 135,560.04 |
| 2022-11-17 | DEPARLE NANCY ANN | director | 26,162 | A-Award | A | 1,402 | 94.93 | 133,091.86 |
| 2022-11-17 | FARAH ROGER N | director | 20,574.897 | A-Award | A | 3,212.8937 | 94.93 | 305,000.00 |
| 2022-11-17 | DECOUDREAUX ALECIA A | director | 25,211.8568 | A-Award | A | 1,323.3435 | 94.93 | 125,625.00 |
| 2022-11-17 | BROWN C DAVID II | director | 72,734.1051 | A-Award | A | 1,402.3491 | 94.93 | 133,125.00 |
| 2022-11-17 | LUDWIG EDWARD J | director | 9,681.4226 | A-Award | A | 1,323.3435 | 94.93 | 125,625.00 |
| 2022-11-17 | LUDWIG EDWARD J | director | 18,630 | A-Award | A | 131 | 94.93 | 12,435.83 |
| 2022-11-17 | AGUIRRE FERNANDO | director | 28,849 | A-Award | A | 1,323 | 94.93 | 125,592.39 |
| 2022-11-17 | Balser Jeffrey R. | director | 1,947 | A-Award | A | 1,323 | 94.93 | 125,592.39 |
| 2022-09-12 | Balser Jeffrey R. | director | 624 | A-Award | A | 406 | 0.00 | 0.00 |
| 2022-08-31 | Shah Prem S | officer: EVP and Co-President of Retail | 20,376 | A-Award | A | 20,376 | 0.00 | 0.00 |
| 2022-08-31 | Mandadi Tilak | officer: EVP, Chief Technology Officer | 99,847 | A-Award | A | 99,847 | 0.00 | 0.00 |
| 2022-08-31 | Chaguturu Sreekanth K | officer: EVP and Chief Medical Officer | 12,735 | A-Award | A | 12,735 | 0.00 | 0.00 |
| 2022-08-04 | Lotvin Alan | officer: EVP&President-PharmacyServices | 0 | M-Exempt | D | 22,541 | 62.21 | 1,402,275.61 |
| 2022-08-04 | Lotvin Alan | officer: EVP&President-PharmacyServices | 20,201 | M-Exempt | D | 50,501 | 54.19 | 2,736,649.19 |
| 2022-08-04 | Lotvin Alan | officer: EVP&President-PharmacyServices | 70,399 | M-Exempt | D | 70,398 | 58.34 | 4,107,019.32 |
| 2022-08-04 | Lotvin Alan | officer: EVP&President-PharmacyServices | 109,183.3689 | S-Sale | D | 22,541 | 104.00 | 2,344,264.00 |
| 2022-08-04 | Lotvin Alan | officer: EVP&President-PharmacyServices | 131,724.3689 | M-Exempt | A | 22,541 | 62.21 | 1,402,275.61 |
| 2022-08-03 | Lotvin Alan | officer: EVP&President-PharmacyServices | 109,183.3689 | S-Sale | D | 50,501 | 98.00 | 4,949,098.00 |
| 2022-08-03 | Lotvin Alan | officer: EVP&President-PharmacyServices | 159,684.3689 | M-Exempt | A | 50,501 | 54.19 | 2,736,649.19 |
| 2022-08-03 | Lotvin Alan | officer: EVP&President-PharmacyServices | 179,581.3689 | M-Exempt | A | 70,398 | 58.34 | 4,107,019.32 |
| 2022-08-03 | Finke Daniel P | officer: EVP/Pres, Health Care Benefits | 19,094 | M-Exempt | D | 9,546 | 52.37 | 499,924.02 |
| 2022-08-03 | Finke Daniel P | officer: EVP/Pres, Health Care Benefits | 32,149.9607 | S-Sale | D | 9,546 | 100.00 | 954,600.00 |
| 2022-08-03 | Finke Daniel P | officer: EVP/Pres, Health Care Benefits | 41,695.9607 | M-Exempt | A | 9,546 | 52.37 | 499,924.02 |
| 2022-06-28 | Moriarty Thomas M | officer: EVP & General Counsel | 116,622 | M-Exempt | D | 38,873 | 74.30 | 2,888,263.90 |
| 2022-06-28 | Moriarty Thomas M | officer: EVP & General Counsel | 50,502 | M-Exempt | D | 50,502 | 54.19 | 2,736,703.38 |
| 2022-06-28 | Moriarty Thomas M | officer: EVP & General Counsel | 98,558 | M-Exempt | D | 49,279 | 58.34 | 2,874,936.86 |
| 2022-06-28 | Moriarty Thomas M | officer: EVP & General Counsel | 665,146 | M-Exempt | A | 38,873 | 74.30 | 2,888,263.90 |
| 2022-06-28 | Moriarty Thomas M | officer: EVP & General Counsel | 626,273 | S-Sale | D | 38,873 | 95.00 | 3,692,935.00 |
| 2022-06-28 | Moriarty Thomas M | officer: EVP & General Counsel | 676,775 | M-Exempt | A | 50,502 | 54.19 | 2,736,703.38 |
| 2022-06-28 | Moriarty Thomas M | officer: EVP & General Counsel | 675,552 | M-Exempt | A | 49,279 | 58.35 | 2,875,429.65 |
| 2022-05-31 | Shah Prem S | officer: EVP and Co-President of Retail | 0 | A-Award | A | 0 | 0.00 | 0.00 |
| 2022-05-31 | Chaguturu Sreekanth K | officer: EVP and Chief Medical Officer | 0 | A-Award | A | 0 | 0.00 | 0.00 |
| 2022-05-31 | Chaguturu Sreekanth K | officer: EVP and Chief Medical Officer | 12,919 | A-Award | A | 12,919 | 0.00 | 0.00 |
| 2022-05-31 | Shah Prem S | officer: EVP and Co-President of Retail | 20,671 | A-Award | A | 20,671 | 0.00 | 0.00 |
| 2022-05-11 | DORMAN DAVID W | director | 109,875 | A-Award | A | 51 | 97.99 | 4,997.49 |
| 2022-05-11 | WHITE TONY L | director | 37,852 | A-Award | A | 38 | 97.99 | 3,723.62 |
| 2022-05-11 | WELDON WILLIAM C | director | 39,397.0255 | A-Award | A | 1,760.3837 | 97.99 | 172,500.00 |
| 2022-05-11 | DEPARLE NANCY ANN | director | 24,760 | A-Award | A | 1,358 | 97.99 | 133,070.42 |
| 2022-05-11 | FARAH ROGER N | director | 17,083.7262 | A-Award | A | 3,112.5625 | 97.99 | 305,000.00 |
| 2022-05-11 | SCHAPIRO MARY L | director | 12,142.2024 | A-Award | A | 1,709.3581 | 97.99 | 167,500.00 |
| 2022-05-11 | LUDWIG EDWARD J | director | 8,222.8902 | A-Award | A | 1,282.0186 | 97.99 | 125,625.00 |
| 2022-05-11 | LUDWIG EDWARD J | director | 18,499 | A-Award | A | 165 | 97.99 | 16,168.35 |
| 2022-05-11 | AGUIRRE FERNANDO | director | 27,526 | A-Award | A | 1,282 | 97.99 | 125,623.18 |
| 2022-05-11 | MILLON JEAN PIERRE | director | 1,409 | A-Award | A | 1,409 | 97.99 | 138,067.91 |
| 2022-05-11 | BROWN C DAVID II | director | 70,123.6827 | A-Award | A | 1,358.557 | 97.99 | 133,125.00 |
| 2022-05-11 | DECOUDREAUX ALECIA A | director | 23,488.6249 | A-Award | A | 1,282.0186 | 97.99 | 125,625.00 |
| 2022-05-11 | Finucane Anne A. | director | 5,892.2482 | A-Award | A | 1,384 | 97.99 | 135,618.16 |
| 2022-04-08 | Shah Prem S | officer: EVP and Co-President of Retail | 28,723 | M-Exempt | D | 4,103 | 74.30 | 304,852.90 |
| 2022-04-08 | Shah Prem S | officer: EVP and Co-President of Retail | 28,596 | M-Exempt | D | 5,719 | 58.34 | 333,646.46 |
| 2022-04-08 | Shah Prem S | officer: EVP and Co-President of Retail | 9,469 | M-Exempt | D | 3,157 | 54.19 | 171,077.83 |
| 2022-04-08 | Shah Prem S | officer: EVP and Co-President of Retail | 846 | M-Exempt | D | 845 | 62.21 | 52,567.45 |
| 2022-04-08 | Shah Prem S | officer: EVP and Co-President of Retail | 43,453.24 | S-Sale | D | 3,130 | 105.00 | 328,650.00 |
| 2022-04-08 | Shah Prem S | officer: EVP and Co-President of Retail | 50,686.24 | M-Exempt | A | 4,103 | 74.30 | 304,852.90 |
| 2022-04-08 | Shah Prem S | officer: EVP and Co-President of Retail | 46,583.24 | S-Sale | D | 4,103 | 105.00 | 430,815.00 |
| 2022-04-08 | Shah Prem S | officer: EVP and Co-President of Retail | 52,302.24 | M-Exempt | A | 5,719 | 58.34 | 333,646.46 |
| 2022-04-08 | Shah Prem S | officer: EVP and Co-President of Retail | 49,740.24 | M-Exempt | A | 3,157 | 54.19 | 171,077.83 |
| 2022-04-08 | Shah Prem S | officer: EVP and Co-President of Retail | 47,428.24 | M-Exempt | A | 845 | 62.21 | 52,567.45 |
| 2022-04-05 | Finke Daniel P | officer: EVP/Pres, Health Care Benefits | 27,166 | M-Exempt | D | 27,166 | 58.34 | 1,584,864.44 |
| 2022-04-05 | Finke Daniel P | officer: EVP/Pres, Health Care Benefits | 16,161 | M-Exempt | D | 16,161 | 54.19 | 875,764.59 |
| 2022-04-05 | Finke Daniel P | officer: EVP/Pres, Health Care Benefits | 32,149.9607 | S-Sale | D | 5,941 | 100.00 | 594,100.00 |
| 2022-04-04 | Finke Daniel P | officer: EVP/Pres, Health Care Benefits | 38,090.9607 | S-Sale | D | 12,032 | 100.13 | 1,204,764.16 |
| 2022-04-04 | Finke Daniel P | officer: EVP/Pres, Health Care Benefits | 50,122.9607 | S-Sale | D | 27,166 | 100.13 | 2,720,131.58 |
| 2022-04-04 | Finke Daniel P | officer: EVP/Pres, Health Care Benefits | 77,288.9607 | M-Exempt | A | 27,166 | 58.34 | 1,584,864.44 |
| 2022-04-04 | Finke Daniel P | officer: EVP/Pres, Health Care Benefits | 66,283.9607 | M-Exempt | A | 16,161 | 54.19 | 875,764.59 |
| 2022-04-03 | Brennan Troyen A | officer: EVP and Chief Medical Officer | 232,676.059 | F-InKind | D | 2,179 | 101.09 | 220,275.11 |
| 2022-04-03 | Moriarty Thomas M | officer: EVP & General Counsel | 46,777 | A-Award | D | 46,777 | 101.09 | 4,728,686.93 |
| 2022-04-03 | Moriarty Thomas M | officer: EVP & General Counsel | 735,349 | F-InKind | D | 3,556 | 101.09 | 359,476.04 |
| 2022-04-01 | PELUSO MICHELLE A | officer: EVP and Co-President of Retail | 57,172 | A-Award | A | 57,172 | 101.09 | 5,779,517.48 |
| 2022-04-01 | Brennan Troyen A | officer: EVP and Chief Medical Officer | 234,855.059 | F-InKind | D | 77,960 | 101.09 | 7,880,976.40 |
| 2022-04-01 | Moriarty Thomas M | officer: EVP & General Counsel | 730,897 | F-InKind | D | 105,854 | 101.09 | 10,700,780.86 |
| 2022-04-01 | Shah Prem S | officer: EVP and Co-President of Retail | 41,580 | A-Award | A | 41,580 | 101.09 | 4,203,322.20 |
| 2022-04-01 | Shah Prem S | officer: EVP and Co-President of Retail | 46,583.24 | F-InKind | D | 3,731 | 101.09 | 377,166.79 |
| 2022-04-01 | Shah Prem S | officer: EVP and Co-President of Retail | 40,324.24 | F-InKind | D | 18,747 | 101.09 | 1,895,134.23 |
| 2022-04-01 | Lotvin Alan | officer: EVP&President-PharmacyServices | 77,962 | A-Award | A | 77,962 | 101.09 | 7,881,178.58 |
| 2022-04-01 | Lotvin Alan | officer: EVP&President-PharmacyServices | 109,183.3689 | F-InKind | D | 38,129 | 101.09 | 3,854,460.61 |
| 2022-04-01 | Lynch Karen S | director, officer: President and CEO | 171,517 | A-Award | A | 171,517 | 101.09 | 17,338,653.53 |
| 2022-04-01 | Lynch Karen S | director, officer: President and CEO | 210,090 | F-InKind | D | 116,940 | 101.09 | 11,821,464.60 |
| 2022-04-01 | GUERTIN SHAWN M | officer: EVP & Chief Financial Officer | 103,950 | A-Award | A | 103,950 | 101.09 | 10,508,305.50 |
Disclaimer: The data contained in this website is not necessarily real-time nor accurate. All derived (stocks, indexes, futures), cryptocurrencies, and Forex prices are not provided by exchanges but rather by our third party API www.financialmodellingprep.com, and so prices may not be accurate and may differ from the actual market price, meaning prices are indicative and not appropriate for trading purposes. Therefore, Discounting Cash Flows Group doesn't bear any responsibility for any trading losses you might incur as a result of using this data. Discounting Cash Flows Group or anyone involved with Discounting Cash Flows Group will not accept any liability for loss or damage as a result of reliance on the information including data, quotes, charts and buy/sell signals contained within this website. Please be fully informed regarding the risks and costs associated with trading the financial markets, it is one of the riskiest investment forms possible.